GGrantIndex
← Leaderboards

Megan Louise Shaw

Icahn School Of Medicine At Mount Sinai

$7,623,476
Attributed
$7,998,043
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200918
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$7,998,043 · 6

By mechanism

U19$4,685,387 · 1
R21$1,317,696 · 3
R01$1,245,825 · 1
R56$749,135 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsVirusVirus ReplicationInfluenzavirusInfluenzaLife Cycle StagesInfectionViralProteinsHigh Throughput ScreeningPathogenVirus DiseasesIntegration Host FactorsResponseComplexRna InterferencePharmaceutical PreparationsTechnologyValidationAntiviral AgentsInhibitor/AntagonistInfluenza A VirusRespiratoryImmune Response

Grant awards (15)

Discovery and validation of pan-influenza antivirals$749,135
R56 · FY2018 · AI · contact PI
Discovery of influenza virus polymerase inhibitors$169,170
R21 · FY2018 · AI · contact PI
Ex vivo interrogation of the genetic and biochemical networks controlling influe$1,205,198
U19 · FY2017 · AI · contact PI
Discovery of influenza virus polymerase inhibitors$231,855
R21 · FY2017 · AI · contact PI
Ex vivo interrogation of the genetic and biochemical networks controlling influe$1,024,857
U19 · FY2016 · AI · contact PI
Ex vivo interrogation of the genetic and biochemical networks controlling influe$870,905
U19 · FY2015 · AI · contact PI
Ex vivo interrogation of the genetic and biochemical networks controlling influe$798,687
U19 · FY2014 · AI · contact PI
A high-throughput screen for antivirals targeting filovirus replication$423,750
R01 · FY2014 · AI · contact PI
Ex vivo interrogation of the genetic and biochemical networks controlling influe$785,740
U19 · FY2013 · AI · contact PI
A high-throughput screen for antivirals targeting filovirus replication$398,325
R01 · FY2013 · AI · contact PI
Host-targeted antivirals for influenza and other respiratory virus infections$251,424
R21 · FY2013 · AI · contact PI
A high-throughput screen for antivirals targeting filovirus replication$423,750
R01 · FY2012 · AI · contact PI
Host-targeted antivirals for influenza and other respiratory virus infections$211,875
R21 · FY2012 · AI · contact PI
INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULES$211,875
R21 · FY2010 · AI · contact PI
INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULES$241,497
R21 · FY2009 · AI · contact PI